ArticleMedChemComm2018

Development of piperazine-1-carbothioamide chitosan silver nanoparticles (P1C-Tit*CAgNPs) as a promising anti-inflammatory candidate: a molecular docking validation.

C S Karthik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.